MedImmune's New R&D Facility and Corporate Headquarters Named 'Best Biotech Office'

Local Chapter of National Office Property Association Awards New MedImmune Facility in Gaithersburg


Gaithersburg. MedImmune, Inc. announced that the Maryland/DC National Association of Industrial and Office Properties has bestowed honors on the company's new facility in Gaithersburg. The company's newly completed state-of-the-art research and development facility and worldwide corporate headquarters was recognized for "Best Biotech Office" and "Best Interiors - Commercial Space" at the association's 2nd Annual Awards of Excellence program held in May 2004 in Washington, DC. The program is designed to honor superior performance in commercial and industrial real estate.

David M. Mott, MedImmune's president and chief executive officer, stated: "As MedImmune has grown over the years, so has our need for expanded facilities that can keep pace with our continuing progress. The new building confirms our commitment to excellence in science and medicine by placing our research functions at its core."

MedImmune's relocation to the building in March 2004 marked the completion of the first of three phases of construction. Designed by HOK Architects, the approximately $88 million building sits on a 22-acre property on Great Seneca Highway in Gaithersburg, Maryland and presently houses more than 600 employees. When fully expanded, the facility may encompass 750,000 square feet and have the capacity for 2,200 employees.

To celebrate the grand opening and recent awards, MedImmune will welcome employees and their families to an Open House on Saturday, June 26. The Open House will feature activities for children, and visitors will have the opportunity to take guided tours highlighting the building's amenities and showcasing the innovative research and development performed by MedImmune researchers. In July, Maryland Governor Robert Ehrlich is expected to perform the official ribbon-cutting for the new facility at a reception for local government and business leaders.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances